| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.11e-05 | 4 | 38 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.37e-04 | 188 | 38 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | methylated histone binding | 5.84e-04 | 86 | 38 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 6.24e-04 | 88 | 38 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone modifying activity | 9.16e-04 | 229 | 38 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.29e-03 | 28 | 38 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.58e-03 | 31 | 38 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.69e-03 | 32 | 38 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.56e-03 | 303 | 38 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | demethylase activity | 3.17e-03 | 44 | 38 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.04e-03 | 562 | 38 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 5.67e-03 | 1160 | 38 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 6.80e-03 | 65 | 38 | 2 | GO:0070063 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 6.80e-03 | 65 | 38 | 2 | GO:0016706 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.00e-03 | 206 | 38 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.90e-03 | 417 | 38 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | p53 binding | 9.43e-03 | 77 | 38 | 2 | GO:0002039 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.76e-06 | 109 | 39 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | mucus layer | 1.02e-05 | 3 | 39 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | filamentous actin | 4.84e-05 | 38 | 39 | 3 | GO:0031941 | |
| Domain | WxxW_domain | 1.10e-07 | 6 | 34 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.10e-07 | 6 | 34 | 3 | PF13330 | |
| Domain | TIL | 1.20e-06 | 12 | 34 | 3 | PF01826 | |
| Domain | C8 | 1.20e-06 | 12 | 34 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.56e-06 | 13 | 34 | 3 | IPR014853 | |
| Domain | C8 | 1.56e-06 | 13 | 34 | 3 | SM00832 | |
| Domain | TIL_dom | 1.98e-06 | 14 | 34 | 3 | IPR002919 | |
| Domain | VWFD | 3.04e-06 | 16 | 34 | 3 | PS51233 | |
| Domain | VWD | 3.04e-06 | 16 | 34 | 3 | SM00216 | |
| Domain | VWF_type-D | 3.04e-06 | 16 | 34 | 3 | IPR001846 | |
| Domain | VWD | 3.04e-06 | 16 | 34 | 3 | PF00094 | |
| Domain | CTCK_1 | 4.41e-06 | 18 | 34 | 3 | PS01185 | |
| Domain | VWC_out | 5.24e-06 | 19 | 34 | 3 | SM00215 | |
| Domain | CT | 8.29e-06 | 22 | 34 | 3 | SM00041 | |
| Domain | Cys_knot_C | 1.23e-05 | 25 | 34 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.23e-05 | 25 | 34 | 3 | PS01225 | |
| Domain | VWFC_1 | 3.78e-05 | 36 | 34 | 3 | PS01208 | |
| Domain | VWC | 4.45e-05 | 38 | 34 | 3 | SM00214 | |
| Domain | VWFC_2 | 4.45e-05 | 38 | 34 | 3 | PS50184 | |
| Domain | VWF_dom | 6.03e-05 | 42 | 34 | 3 | IPR001007 | |
| Domain | SEA | 2.89e-04 | 14 | 34 | 2 | SM00200 | |
| Domain | Glyco_hormone_CN | 3.33e-04 | 15 | 34 | 2 | IPR006208 | |
| Domain | Cys_knot | 3.33e-04 | 15 | 34 | 2 | PF00007 | |
| Domain | SEA | 7.95e-04 | 23 | 34 | 2 | PS50024 | |
| Domain | SEA_dom | 7.95e-04 | 23 | 34 | 2 | IPR000082 | |
| Domain | JmjC | 8.66e-04 | 24 | 34 | 2 | PF02373 | |
| Domain | VWC | 1.18e-03 | 28 | 34 | 2 | PF00093 | |
| Domain | JMJC | 1.54e-03 | 32 | 34 | 2 | PS51184 | |
| Domain | JmjC_dom | 1.54e-03 | 32 | 34 | 2 | IPR003347 | |
| Domain | JmjC | 1.64e-03 | 33 | 34 | 2 | SM00558 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.38e-08 | 16 | 25 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.80e-08 | 17 | 25 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.51e-08 | 21 | 25 | 4 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.66e-08 | 23 | 25 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.12e-07 | 26 | 25 | 4 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.51e-06 | 60 | 25 | 4 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.00e-06 | 62 | 25 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.80e-06 | 68 | 25 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.77e-05 | 109 | 25 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.05e-05 | 111 | 25 | 4 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.00e-04 | 140 | 25 | 4 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.09e-04 | 143 | 25 | 4 | M27275 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 2.00e-04 | 65 | 25 | 3 | M38994 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 3.98e-04 | 82 | 25 | 3 | M27626 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 9.11e-04 | 250 | 25 | 4 | M27554 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.19e-03 | 29 | 25 | 2 | MM14934 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.15e-03 | 39 | 25 | 2 | MM15272 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.26e-03 | 40 | 25 | 2 | M27557 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 2.85e-03 | 45 | 25 | 2 | M27623 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 3.51e-03 | 50 | 25 | 2 | M27232 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.15e-11 | 18 | 39 | 5 | 18834073 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 19718741 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 23807779 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 25638393 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 17471237 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 5.21e-09 | 4 | 39 | 3 | 22269464 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 14984930 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 12676567 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 5.21e-09 | 4 | 39 | 3 | 29869461 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.30e-08 | 5 | 39 | 3 | 11062147 | |
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 1.30e-08 | 5 | 39 | 3 | 16188033 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 19110483 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.49e-07 | 774 | 39 | 9 | 15302935 | |
| Pubmed | PHF2 NOL4L POGZ ZNF362 TCERG1 TRIM24 MNDA EMSY TP53BP1 PRDM2 | 2.72e-07 | 1103 | 39 | 10 | 34189442 | |
| Pubmed | 3.80e-07 | 418 | 39 | 7 | 34709266 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7513696 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.23e-06 | 2 | 39 | 2 | 23272068 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17203232 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.23e-06 | 2 | 39 | 2 | 27729120 | |
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 1.23e-06 | 2 | 39 | 2 | 20731025 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 34058148 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 37146737 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.23e-06 | 2 | 39 | 2 | 23527003 | |
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.23e-06 | 2 | 39 | 2 | 14988081 | |
| Pubmed | Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. | 1.23e-06 | 2 | 39 | 2 | 17330845 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 16540890 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15563276 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 36111525 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17621824 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24317696 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.23e-06 | 2 | 39 | 2 | 27845589 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 11445551 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22391959 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.23e-06 | 2 | 39 | 2 | 35776514 | |
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 1.23e-06 | 2 | 39 | 2 | 12527922 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27435107 | ||
| Pubmed | Study of mucin turnover in the small intestine by in vivo labeling. | 1.23e-06 | 2 | 39 | 2 | 29636525 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24327612 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26871672 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23832517 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23832516 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 1.23e-06 | 2 | 39 | 2 | 20873538 | |
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.23e-06 | 2 | 39 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.23e-06 | 2 | 39 | 2 | 36427316 | |
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 1.23e-06 | 2 | 39 | 2 | 14594655 | |
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.23e-06 | 2 | 39 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.23e-06 | 2 | 39 | 2 | 11587997 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.23e-06 | 2 | 39 | 2 | 28607090 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.23e-06 | 2 | 39 | 2 | 24332705 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12820724 | ||
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 1.23e-06 | 2 | 39 | 2 | 34656442 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17321686 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20065027 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27776277 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18300795 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 3.67e-06 | 3 | 39 | 2 | 34158522 | |
| Pubmed | Gene expression profiling of colorectal mucinous adenocarcinomas. | 3.67e-06 | 3 | 39 | 2 | 20485009 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 3.67e-06 | 3 | 39 | 2 | 29604272 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 29286856 | ||
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 3.67e-06 | 3 | 39 | 2 | 19596978 | |
| Pubmed | Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. | 3.67e-06 | 3 | 39 | 2 | 17333267 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 36675209 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 3.67e-06 | 3 | 39 | 2 | 18163520 | |
| Pubmed | Differences in the expression of mucins in various forms of cystitis glandularis. | 3.67e-06 | 3 | 39 | 2 | 17659847 | |
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 3.67e-06 | 3 | 39 | 2 | 19556605 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11352827 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23464473 | ||
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 3.67e-06 | 3 | 39 | 2 | 21455588 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 29802623 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 3.67e-06 | 3 | 39 | 2 | 20422702 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24920497 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18825309 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 10512748 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 21596555 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 33154304 | ||
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 7.34e-06 | 4 | 39 | 2 | 31582416 | |
| Pubmed | Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. | 7.34e-06 | 4 | 39 | 2 | 12391274 | |
| Pubmed | Recognition of unknown conserved alternatively spliced exons. | 7.34e-06 | 4 | 39 | 2 | 16110330 | |
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 7.34e-06 | 4 | 39 | 2 | 24901817 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 7.34e-06 | 4 | 39 | 2 | 27298226 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 36367122 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 23619266 | ||
| Pubmed | MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. | 7.34e-06 | 4 | 39 | 2 | 21097527 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 23249391 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 22691042 | ||
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 7.34e-06 | 4 | 39 | 2 | 18198997 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 7.34e-06 | 4 | 39 | 2 | 17401217 | |
| Pubmed | Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. | 7.34e-06 | 4 | 39 | 2 | 18258655 | |
| Pubmed | [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. | 7.34e-06 | 4 | 39 | 2 | 17991319 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 25298197 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 7.34e-06 | 4 | 39 | 2 | 20929551 | |
| Pubmed | pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. | 1.22e-05 | 5 | 39 | 2 | 10611155 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 22261707 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12507512 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 24840470 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12135769 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 18035521 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.22e-05 | 5 | 39 | 2 | 16475027 | |
| Interaction | ASF1A interactions | 7.77e-06 | 249 | 39 | 6 | int:ASF1A | |
| Cytoband | 11p15.5 | 1.41e-04 | 118 | 39 | 3 | 11p15.5 | |
| GeneFamily | CD molecules|Mucins | 6.62e-11 | 21 | 25 | 5 | 648 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.97e-04 | 24 | 25 | 2 | 485 | |
| GeneFamily | PHD finger proteins | 6.82e-03 | 90 | 25 | 2 | 88 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.21e-06 | 170 | 39 | 5 | M5880 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.72e-05 | 255 | 38 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 1.92e-04 | 161 | 38 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.55e-04 | 721 | 38 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.57e-04 | 722 | 38 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.75e-04 | 730 | 38 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.16e-04 | 747 | 38 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.16e-04 | 747 | 38 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| ToppCell | normal-na-Myeloid-conventional_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.72e-07 | 185 | 39 | 5 | 67e881a89a491665b8c612fff084c202c0c79235 | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.80e-07 | 197 | 39 | 5 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.41e-07 | 200 | 39 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-05 | 167 | 39 | 4 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-05 | 172 | 39 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 179 | 39 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-05 | 180 | 39 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-05 | 180 | 39 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 182 | 39 | 4 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.91e-05 | 182 | 39 | 4 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 182 | 39 | 4 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 182 | 39 | 4 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.95e-05 | 183 | 39 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 183 | 39 | 4 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.99e-05 | 184 | 39 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.26e-05 | 190 | 39 | 4 | 4b25d49f033bbd326b47cf5602af3f0262cfc367 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 191 | 39 | 4 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 191 | 39 | 4 | c7b95a5f9185d533c08754ce2e4ce91533eb612e | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.35e-05 | 192 | 39 | 4 | 8e606eae3e5b07a856d3c2a74186d486da96309c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-05 | 192 | 39 | 4 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| ToppCell | VE-mDC1|VE / Condition, Cell_class and T cell subcluster | 2.40e-05 | 193 | 39 | 4 | 12b2708db9db8b88365b8ebeb4908f28c50081bb | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 193 | 39 | 4 | 984ea5b871479527ab57dd813bacae844c0d8c06 | |
| ToppCell | VE-mDC1-|VE / Condition, Cell_class and T cell subcluster | 2.40e-05 | 193 | 39 | 4 | 5df6033bc0e4f96a20d526486a8e89c990e21831 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 193 | 39 | 4 | 529281b912070c8655e38880ac73f5e4bd6ee4ce | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-05 | 194 | 39 | 4 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.45e-05 | 194 | 39 | 4 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 196 | 39 | 4 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 196 | 39 | 4 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.55e-05 | 196 | 39 | 4 | 0bac14c018487ca67e7f9255b5f186e7ae665774 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 196 | 39 | 4 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-05 | 196 | 39 | 4 | 33345338c825484960daa1ed82a19df38ccfc5c0 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.60e-05 | 197 | 39 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-05 | 198 | 39 | 4 | 42be18aef4f656a86c61630b061826a858c496fd | |
| ToppCell | Transverse-(5)_Dendritic_cell-(51)_cDC1|Transverse / shred on region, Cell_type, and subtype | 2.71e-05 | 199 | 39 | 4 | 52dd1c4cd372f8ee515307a9200e357bb2145888 | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Transverse / Region, Cell class and subclass | 2.71e-05 | 199 | 39 | 4 | b68419939d206417158a703f60a374bf8ec5d5a1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.59e-04 | 142 | 39 | 3 | 43524c10f446c9da079cff52800326a1d4675452 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 156 | 39 | 3 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 156 | 39 | 3 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 3.41e-04 | 156 | 39 | 3 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.54e-04 | 158 | 39 | 3 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.54e-04 | 158 | 39 | 3 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.54e-04 | 158 | 39 | 3 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 159 | 39 | 3 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-04 | 159 | 39 | 3 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 162 | 39 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 162 | 39 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.81e-04 | 162 | 39 | 3 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.95e-04 | 164 | 39 | 3 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.95e-04 | 164 | 39 | 3 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.95e-04 | 164 | 39 | 3 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 164 | 39 | 3 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 164 | 39 | 3 | 911081739174ec68bc0893c804e4276b206bea7d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 164 | 39 | 3 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.23e-04 | 168 | 39 | 3 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-04 | 168 | 39 | 3 | b275e951ff7109e36da22fc17bd4516f9b9432c4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-04 | 168 | 39 | 3 | 0757a5af953901a8faed5774ffec4755fc9c0a6e | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | 6c7b490b6c844d0ea4c07edfc24c02284f9533c4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-04 | 168 | 39 | 3 | a0dbe2ee697e29b32aa5f8326445e067ff66c154 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.31e-04 | 169 | 39 | 3 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-04 | 169 | 39 | 3 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-04 | 169 | 39 | 3 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-04 | 169 | 39 | 3 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 170 | 39 | 3 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.46e-04 | 171 | 39 | 3 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.61e-04 | 173 | 39 | 3 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.61e-04 | 173 | 39 | 3 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-04 | 175 | 39 | 3 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-04 | 178 | 39 | 3 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.01e-04 | 178 | 39 | 3 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-04 | 178 | 39 | 3 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 5.09e-04 | 179 | 39 | 3 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-04 | 179 | 39 | 3 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-04 | 179 | 39 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.09e-04 | 179 | 39 | 3 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.09e-04 | 179 | 39 | 3 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.09e-04 | 179 | 39 | 3 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.18e-04 | 180 | 39 | 3 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 180 | 39 | 3 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.18e-04 | 180 | 39 | 3 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 180 | 39 | 3 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.35e-04 | 182 | 39 | 3 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-04 | 183 | 39 | 3 | 514b72a1ae55656934839800513385e19bc240e2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-04 | 184 | 39 | 3 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-04 | 184 | 39 | 3 | 41164109d9d7bb1c431220e2e85e08dc5f56856d | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-04 | 184 | 39 | 3 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.52e-04 | 184 | 39 | 3 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-04 | 184 | 39 | 3 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 8.52e-07 | 197 | 38 | 6 | 4679_UP | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 1.54e-05 | 190 | 38 | 5 | 1103_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; PC3; HT_HG-U133A | 1.83e-05 | 197 | 38 | 5 | 4654_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 4462_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.93e-05 | 199 | 38 | 5 | 4606_UP | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.13e-08 | 5 | 39 | 3 | DOID:3030 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.56e-06 | 64 | 39 | 4 | DOID:4947 (is_marker_for) | |
| Disease | cystitis (is_marker_for) | 1.70e-06 | 2 | 39 | 2 | DOID:1679 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 5.10e-06 | 3 | 39 | 2 | OBA_2050332 | |
| Disease | eosinophil count | SYN2 NOL4L ZNF362 KDM6B MUC2 MUC5AC GLCCI1 EMSY TP53BP1 HECTD4 | 1.71e-05 | 1488 | 39 | 10 | EFO_0004842 |
| Disease | chronic obstructive pulmonary disease | 2.92e-05 | 688 | 39 | 7 | EFO_0000341 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 4.74e-05 | 8 | 39 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis | 5.94e-05 | 57 | 39 | 3 | EFO_0000768 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 6.09e-05 | 9 | 39 | 2 | EFO_0009824 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 7.29e-05 | 61 | 39 | 3 | DOID:3587 (is_marker_for) | |
| Disease | cystic fibrosis (is_marker_for) | 7.65e-05 | 62 | 39 | 3 | DOID:1485 (is_marker_for) | |
| Disease | pulmonary fibrosis | 9.29e-05 | 11 | 39 | 2 | EFO_0009448 | |
| Disease | interstitial lung disease | 9.64e-05 | 67 | 39 | 3 | EFO_0004244 | |
| Disease | body weight | 2.05e-04 | 1261 | 39 | 8 | EFO_0004338 | |
| Disease | Inhalant adrenergic use measurement | 2.80e-04 | 96 | 39 | 3 | EFO_0009941 | |
| Disease | basophil count, eosinophil count | 2.85e-04 | 241 | 39 | 4 | EFO_0004842, EFO_0005090 | |
| Disease | adult onset asthma | 5.13e-04 | 118 | 39 | 3 | EFO_1002011 | |
| Disease | glycoprotein measurement | 5.26e-04 | 119 | 39 | 3 | EFO_0004555 | |
| Disease | unipolar depression, depressive symptom measurement | 5.42e-04 | 26 | 39 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | soluble triggering receptor expressed on myeloid cells 2 measurement | 6.19e-04 | 296 | 39 | 4 | EFO_0010151 | |
| Disease | Sclerocystic Ovaries | 9.15e-04 | 144 | 39 | 3 | C1136382 | |
| Disease | stroke | 9.15e-04 | 144 | 39 | 3 | EFO_0000712 | |
| Disease | Polycystic Ovary Syndrome | 9.15e-04 | 144 | 39 | 3 | C0032460 | |
| Disease | carbohydrate intake measurement | 9.30e-04 | 34 | 39 | 2 | EFO_0010811 | |
| Disease | respiratory system disease | 9.33e-04 | 145 | 39 | 3 | EFO_0000684 | |
| Disease | differentiated thyroid carcinoma | 9.85e-04 | 35 | 39 | 2 | EFO_1002017 | |
| Disease | COVID-19 symptoms measurement | 9.85e-04 | 35 | 39 | 2 | EFO_0600019 | |
| Disease | spleen volume | 1.49e-03 | 43 | 39 | 2 | EFO_0600047 | |
| Disease | pneumonia | 1.77e-03 | 47 | 39 | 2 | EFO_0003106 | |
| Disease | neutrophil count | 2.01e-03 | 1382 | 39 | 7 | EFO_0004833 | |
| Disease | substance-related disorder | 2.16e-03 | 52 | 39 | 2 | MONDO_0002494 | |
| Disease | Antithrombotic agent use measurement | 2.42e-03 | 55 | 39 | 2 | EFO_0009925 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.42e-03 | 55 | 39 | 2 | EFO_0022234 | |
| Disease | cognitive behavioural therapy | 2.69e-03 | 58 | 39 | 2 | EFO_0007820 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 2.78e-03 | 59 | 39 | 2 | EFO_0001663, MONDO_0005148 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.78e-03 | 59 | 39 | 2 | EFO_0022248 | |
| Disease | eosinophil percentage of leukocytes | 2.88e-03 | 746 | 39 | 5 | EFO_0007991 | |
| Disease | breast carcinoma (is_marker_for) | 3.46e-03 | 66 | 39 | 2 | DOID:3459 (is_marker_for) | |
| Disease | systemic lupus erythematosus | 3.86e-03 | 799 | 39 | 5 | MONDO_0007915 | |
| Disease | mean reticulocyte volume | 3.86e-03 | 799 | 39 | 5 | EFO_0010701 | |
| Disease | mean arterial pressure | 4.16e-03 | 499 | 39 | 4 | EFO_0006340 | |
| Disease | endometriosis | 4.48e-03 | 252 | 39 | 3 | EFO_0001065 | |
| Disease | Drugs used in diabetes use measurement | 4.63e-03 | 255 | 39 | 3 | EFO_0009924 | |
| Disease | tonsillectomy risk measurement | 4.89e-03 | 260 | 39 | 3 | EFO_0007924 | |
| Disease | cholesterol in large HDL measurement | 5.04e-03 | 80 | 39 | 2 | EFO_0021900 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVNSPSTTPPTVTTN | 381 | Q86SQ4 | |
| SVSSPTSSNTPTPTK | 131 | Q5M775 | |
| SSSSSSSSQTPHPPS | 6 | Q86VQ1 | |
| PSTPATSSTATPSST | 1886 | Q9HC84 | |
| SSSTQTSGTPPSLTT | 2121 | Q9HC84 | |
| TITATGSTTNPSSTP | 2696 | Q9HC84 | |
| CPSTPATSSTATPSS | 2971 | Q9HC84 | |
| TITATGSTTNPSSTP | 3396 | Q9HC84 | |
| CPSTPATSSTATPSS | 3671 | Q9HC84 | |
| TITATGSTTNPSSTP | 4686 | Q9HC84 | |
| PPTPTTSSSNSNSGS | 546 | O15054 | |
| SNPSSTTSSTPSSPA | 446 | Q8IVT5 | |
| TTTGSSSAPTPSTVQ | 4286 | Q02817 | |
| PSFTSSVSSSTPVPS | 1791 | Q02505 | |
| CSTSSSPAQTTPPTT | 1481 | P98088 | |
| STPGSTSSSPAQTTP | 1851 | P98088 | |
| PSPVPTTSTTSATTT | 2396 | P98088 | |
| PSPVPTASTTSASTT | 2636 | P98088 | |
| SPVPTTSTTSAPTTS | 2701 | P98088 | |
| SSPVPTTSTTSAPTT | 2836 | P98088 | |
| SPVPTTSTTSAPTTS | 2981 | P98088 | |
| SAPTTSTPSAPTTST | 3006 | P98088 | |
| STPSAPTTSTTLAPT | 3011 | P98088 | |
| TTPSPVPTTSTASVS | 3186 | P98088 | |
| PTTSTTPASIPSTTS | 3676 | P98088 | |
| TPASIPSTTSAPTTS | 3681 | P98088 | |
| PSTTSAPTTSTTSAP | 3686 | P98088 | |
| STTSPPTSSTSSTPQ | 3886 | P98088 | |
| PQTSTTSAPTTSTIP | 4101 | P98088 | |
| TSAPTTSTIPASTPS | 4106 | P98088 | |
| TSTIPASTPSTTSAP | 4111 | P98088 | |
| SGTTPSPVPTTSTTS | 4221 | P98088 | |
| TPSPVPSTSTTSAAT | 4256 | P98088 | |
| SPVPTTSTTSAPTTS | 4346 | P98088 | |
| GSTPSPVPTTSTTSA | 4406 | P98088 | |
| PSPVPTTSTTSASTT | 4441 | P98088 | |
| SPVPTTSTTSAPTTS | 4546 | P98088 | |
| PVPTTSTTSAPTTST | 4571 | P98088 | |
| SSSSSSPGQTPQSPS | 2871 | Q9Y4D8 | |
| TTSTTPTPTPSSTST | 376 | Q96MY1 | |
| STTTTTAASTTPTPP | 3491 | Q7Z6Z7 | |
| TPSSSSSQTSPASQP | 1871 | O95996 | |
| TPFPSPSSSTSSSSS | 251 | Q9P278 | |
| PPSLSSSSSSSPTSG | 66 | Q8IV03 | |
| YTSTTSTPTSTPVPS | 146 | Q7Z589 | |
| TPSTNTTRTPSPTSS | 436 | D6RIA3 | |
| PGPPTLSSSSSSSSS | 1046 | Q13029 | |
| PQTSSSTPSNTSFTP | 176 | P41218 | |
| STPVTTSSPTNSSPT | 3486 | Q685J3 | |
| PSLPPSSSSSSSSSS | 481 | Q92777 | |
| PSPAPSSSSSSSSST | 576 | Q8N1G1 | |
| TTPASTTPASTTPAS | 981 | O75151 | |
| STPSTSTTPTATQPT | 251 | Q7Z3K3 | |
| GTSPTTSSTGTPSPS | 346 | Q96SF7 | |
| TSSNTSIPTPSSSPF | 631 | O60284 | |
| PTSSVATPSSTISTP | 326 | Q8WXI2 | |
| TPSPPVSTFSSGTST | 241 | P82094 | |
| GTPSTTNSTSSTPSS | 576 | O15164 | |
| PSGSSSTSSTPLSSP | 51 | Q9Y6Q2 | |
| PTTSSPAPAVSTSTS | 261 | O14776 | |
| PAPAVSTSTSSSTPS | 266 | O14776 | |
| SSASSSPSPSPSSSS | 191 | Q9H7N4 | |
| SSPSTSSPSSSSPSS | 216 | Q17RH7 | |
| SSPSSSSPSSSSPSS | 221 | Q17RH7 | |
| PATPTASSSSSTTPT | 1636 | Q12888 | |
| TLSTSPSPSSPSPTS | 316 | Q9H330 | |
| GTSTPSTPTTTSQSR | 141 | Q5T0B9 | |
| GSTSSSPASPSSSPT | 196 | P53814 | |
| PSSTVSSAGPSSPTT | 1171 | Q6PFW1 | |
| IPASSATSPSTPTST | 2596 | Q15911 |